Federation Des Caisses Desjardins Du Quebec Bristol Myers Squibb CO Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 174,376 shares of BMY stock, worth $9.28 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

174,376

Previous 110,393 57.96%

Holding current value

$9.28 Million

Previous $5.88 Billion 99.88%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $2.58 Million - $3.39 Million	63,983 Added 57.96%	174,376 $7.24 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $5.3 Million - $6.01 Million	110,393 New	110,393 $5.88 Billion
Q4 2023 Aug 14, 2024	SELL	$48.48 - $57.85 $1.48 Million - $1.76 Million	-30,505 Reduced 31.35%	66,790 $3.43 Billion
Q3 2023 Aug 14, 2024	SELL	$57.89 - $64.73 $734,334 - $821,100	-12,685 Reduced 11.53%	97,295 $5.65 Billion
Q2 2023 Aug 14, 2024	BUY	$63.71 - $70.74 $2.73 Million - $3.04 Million	42,918 Added 64.0%	109,980 $7.03 Billion
Q1 2023 Aug 14, 2024	SELL	$65.71 - $74.53 $2.01 Million - $2.28 Million	-30,574 Reduced 31.31%	67,062 $4.65 Billion
Q4 2022 Aug 14, 2024	SELL	$68.48 - $81.09 $3.45 Million - $4.09 Million	-50,381 Reduced 34.04%	97,636 $7.02 Billion
Q3 2022 Aug 14, 2024	SELL	$0.13 - $76.84 $18,640 - $11 Million	-143,389 Reduced 49.21%	148,017 $10.5 Billion
Q2 2022 Aug 14, 2024	SELL	$72.62 - $79.98 $18.5 Million - $20.3 Million	-254,246 Reduced 46.59%	291,406 $22.4 Billion
Q1 2022 Aug 14, 2024	BUY	$61.48 - $73.72 $22.8 Million - $27.4 Million	371,276 Added 212.92%	545,652 $39.8 Billion
Q4 2021 Aug 30, 2024	BUY	$53.63 - $62.52 $1.33 Million - $1.55 Million	24,766 Added 4.9%	529,938 $33 Billion
Q3 2021 Aug 30, 2024	BUY	$59.17 - $69.31 $601,108 - $704,120	10,159 Added 2.05%	505,172 $29.9 Billion
Q2 2021 Aug 30, 2024	BUY	$61.91 - $67.42 $19.9 Million - $21.6 Million	320,637 Added 183.88%	495,013 $33.1 Billion
Q1 2021 Aug 30, 2024	BUY	$59.34 - $66.74 $1.36 Million - $1.53 Million	22,856 Added 4.52%	528,485 $33.4 Billion
Q4 2020 Aug 30, 2024	BUY	$57.74 - $65.43 $4.67 Million - $5.29 Million	80,886 Added 19.04%	505,629 $31.4 Billion
Q3 2020 Aug 30, 2024	BUY	$57.43 - $63.64 $159,827 - $177,110	2,783 Added 0.66%	424,743 $25.6 Billion
Q2 2020 Aug 30, 2024	BUY	$54.82 - $64.09 $4.67 Million - $5.46 Million	85,190 Added 25.3%	421,960 $24.8 Billion
Q1 2020 Aug 30, 2024	SELL	$46.4 - $67.43 $6.35 Million - $9.23 Million	-136,823 Reduced 28.89%	336,770 $18.8 Billion
Q4 2019 Aug 30, 2024	BUY	$49.21 - $64.19 $5.72 Million - $7.46 Million	116,293 Added 32.55%	473,593 $30.4 Billion
Q3 2019 Aug 30, 2024	BUY	$42.77 - $50.71 $5.55 Million - $6.58 Million	129,782 Added 57.04%	357,300 $18.1 Billion
Q2 2019 Aug 30, 2024	BUY	$44.62 - $49.34 $179,372 - $198,346	4,020 Added 1.8%	227,518 $10.3 Billion
Q1 2019 Aug 30, 2024	BUY	$45.12 - $53.8 $8.12 Million - $9.68 Million	179,904 Added 412.68%	223,498 $10.7 Billion
Q4 2018 Aug 30, 2024	SELL	$48.76 - $63.23 $6.38 Million - $8.27 Million	-130,782 Reduced 75.0%	43,594 $2.27 Billion
Q3 2018 Aug 30, 2024	SELL	$55.19 - $62.25 $152,655 - $172,183	-2,766 Reduced 5.81%	44,830 $2.78 Billion
Q2 2018 Aug 30, 2024	BUY	$50.53 - $62.98 $419,297 - $522,608	8,298 Added 21.12%	47,596 $2.63 Billion
Q1 2018 Aug 30, 2024	BUY	$59.92 - $68.98 $248,548 - $286,129	4,148 Added 11.8%	39,298 $2.49 Billion
Q4 2017 Aug 30, 2024	BUY	$59.94 - $65.35 $23,196 - $25,290	387 Added 1.11%	35,150 $2.15 Billion
Q3 2017 Aug 30, 2024	SELL	$55.23 - $63.74 $362,032 - $417,815	-6,555 Reduced 15.86%	34,763 $2.22 Billion
Q2 2017 Aug 30, 2024	BUY	N/A	2,524 Added 6.51%	41,318 $2.3 Billion
Q1 2017 Aug 30, 2024	SELL	N/A	-135,582	38,794 $2.11 Billion

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Bristol Myers Squibb CO Transaction History